Abstract
Atopic dermatitis (AD) is a complex inflammatory skin disease that frequently develops in childhood and can last into adulthood. It can be very painful and harm a person's quality of life. The exact cause of atopic dermatitis is not fully known but is believed to be a combination of genetic disorders and environmental factors. Currently used drugs in the treatment are topical corticosteroids and topical calcineurin inhibitors. This comprehensive review summarizes the pathophysiology of atopic dermatitis, therapeutic targets, current treatment, newer and emerging therapies in AD treatment, and the role of nanoparticles in formulation development for AD treatment.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
